title: Value of magnetic resonance cholangiography (MRC) in primary sclerosing cholangitis (PSC).
abstract: BACKGROUND
  Magnetic resonance cholangiography is a relatively new method, hence it has not gained a proper status yet in the diagnostic algorithm in patients with bile duct diseases. Many authors believe that MRC is an effective method for the visualisation of bile ducts. The aim of the study is to evaluate MRC usefulness in patients with PSC.
  
  
  METHODS
  The study material consisted of 4 patients with PSC (3 men and 1 woman) aged 23-50 years. Patients were subjected to liver MRI in transverse plane, and T1 and T2-weighted images were obtained. Additionally, magnetic resonance cholangiography was performed with Gyroscan 0.5 T unit and Magnevist contrast medium.
  
  
  RESULTS
  The patients manifested cholestasis and hepatitis of different duration (range: 2-14 years). The biochemical analyses revealed FA ranging from 563 to 1114 IU/l, GGTP 157-1270 IU/L, AlAT 56-295 IU/L, AspAT 80-190 IU/L. Three out of four patients displayed significant increase in the level of ANCA antibodies. Histopathological investigation of the liver, conducted in 3 out of 4 patients, showed cholangitis et pericholangitis. ERCP was attempted in all the patients. In one case, irregular, overlapping and narrowed bile ducts were found, while in two cases it was impossible to fill intrahepatic ducts. ERCP was not performed due to technical obstacles encountered in one patient. All the subjects underwent MRC. In three cases, the segmental irregular dilatation of intrahepatic ducts was observed, while in one case intrahepatic ducts were poorly marked. The defect in the filling of initial segment of common bile duct was diagnosed in one patient. Another patient had a lesion adjacent to common bile duct--low signal intensity in T1 and the intensification after the administration of contrast medium indicate the presence of expansive process.
  
  
  CONCLUSIONS
  1. MRC is an accurate examination enabling the visualisation of all bile ducts in their natural size. 2. Simultaneous MRI of the liver allows for the diagnosis of focal lesions. 3. MRC may be used in those cases, where ERCP cannot be performed for technical reasons or when it is objected by the patient.
authors.affiliation: Department of Infectious Diseases, Medical University in Gdańsk, ul. Smoluchowskiego 18, 80-214 Gdańsk, Poland.
authors.forename: K
authors.initials: K
authors.lastname: Witczak-Malinowska
authors.forename: T
authors.initials: T
authors.lastname: Gorycki
authors.forename: P
authors.initials: P
authors.lastname: Stalke
authors.forename: Z
authors.initials: Z
authors.lastname: Michalska
authors.forename: M
authors.initials: M
authors.lastname: Jankowska
mesh_terms: D000328:Adult; D002758:Cholangiography / Q000379:methods*; D015209:Cholangitis, Sclerosing / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D005260:Female; D006505:Hepatitis / Q000175:diagnosis / Q000000981:diagnostic imaging; D006801:Humans; D008099:Liver / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity